Table 3 Induction therapy in patients received mycophenolate
Total | Non-Indigenous Australians | Indigenous Australians | P-value | |
|---|---|---|---|---|
No. of Patients | 20 | 5 | 15 | |
Mean eGFRa (ml/min/1.73 m2) | 76 (± 41.4) | 75.3 (± 43.1) | 0.976 | |
Mean Creatinine (μmol/L) | 143.0 (± 22.26) | 145.6 (± 131.4) | 142.1 (± 92.25) | 0.947 |
Mean ACR (g/mol) | 289.71 (± 70.7) | 135.6 (± 187.7) | 341 (± 338.3) | 0.217 |
Total MMF dose (g, mean ± SD) | 285 ± 117.57 | 374.6 ± 97.4 | 255.9 ± 110.79 | 0.047 |
Total Prednisolone dose (mg, mean ± SD) | 3735 ± 1959 | 3734 ± 1674.2 | 3736 ± 2100.3 | 0.999 |
Number of patients received Pulse methylprednisolone | 8 (40%) | 3 (60%) | 5 (33%) | 0.347 |